Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens Reports Sale of $296,469.54 in Common Shares
Bitget2026/10/28 20:03- Agios Pharmaceuticals Chief Medical Officer Sarah Gheuens sold 7,866 common shares Oct. 26, 2026, at a weighted-average price of $37.69.
- Gheuens exercised stock options to acquire 7,866 common shares at $25.01 per share the same day.
- Following the transactions, she directly owned 54,645 common shares and 16,275 stock options.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
Crypto prices
More
